These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 9437767

  • 1. Behavioral activity of 1S,3R-ACPD, an agonist of metabotropic glutamate receptors.
    Zalewska A, Wiśniewski K.
    Pol J Pharmacol; 1997 Aug; 49(4):239-48. PubMed ID: 9437767
    [Abstract] [Full Text] [Related]

  • 2. The influence of 1S,3R-ACPD on central dopaminergic transmission and recognition memory.
    Zalewska A, Wiśniewski K.
    Acta Physiol Hung; 1996 Aug; 84(4):481-2. PubMed ID: 9328638
    [Abstract] [Full Text] [Related]

  • 3. Central activity of 2-amino-4-phosphonobutyric acid (AP4).
    Zalewska A, Winnicka MM, Wiśniewski K.
    Pol J Pharmacol; 1995 Aug; 47(1):9-17. PubMed ID: 7550555
    [Abstract] [Full Text] [Related]

  • 4. Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4).
    Zalewska A, Winnicka MM, Wiśniewski K.
    Pol J Pharmacol; 1996 Aug; 48(4):415-23. PubMed ID: 9112682
    [Abstract] [Full Text] [Related]

  • 5. Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat.
    Attarian S, Amalric M.
    Eur J Neurosci; 1997 Apr; 9(4):809-16. PubMed ID: 9153588
    [Abstract] [Full Text] [Related]

  • 6. Central activity of 2-amino-3-phosphonopropionic acid (AP3) and its N-methyl analog.
    Winnicka MM, Wiśniewski K, Kupczyk-Subotkowska L, Subotkowski W, Mastalerz P.
    Pol J Pharmacol; 1994 Apr; 46(5):395-401. PubMed ID: 7894525
    [Abstract] [Full Text] [Related]

  • 7. Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes.
    Ye ZC, Sontheimer H.
    Glia; 1999 Feb 01; 25(3):270-81. PubMed ID: 9932873
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist.
    Moroni F, Lombardi G, Thomsen C, Leonardi P, Attucci S, Peruginelli F, Torregrossa SA, Pellegrini-Giampietro DE, Luneia R, Pellicciari R.
    J Pharmacol Exp Ther; 1997 May 01; 281(2):721-9. PubMed ID: 9152378
    [Abstract] [Full Text] [Related]

  • 9. Behavioural activity of (S)-3,5-DHPG, a selective agonist of group I metabotropic glutamate receptors.
    Zalewska-Wińska A, Wiśniewski K.
    Pharmacol Res; 2000 Sep 01; 42(3):239-45. PubMed ID: 10945930
    [Abstract] [Full Text] [Related]

  • 10. 1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.
    Kronthaler UO, Schmidt WJ.
    Eur J Pharmacol; 1996 Dec 05; 316(2-3):129-36. PubMed ID: 8982678
    [Abstract] [Full Text] [Related]

  • 11. L-AP4, a potent agonist of group III metabotropic glutamate receptor, decreases central action of angiotensin II.
    Fedosiewicz-Wasiluk M, Hoły ZZ, Wiśniewski K.
    Pol J Pharmacol; 2002 Dec 05; 54(5):415-22. PubMed ID: 12593528
    [Abstract] [Full Text] [Related]

  • 12. Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine.
    Camón L, Vives P, de Vera N, Martínez E.
    J Neurosci Res; 1998 Feb 01; 51(3):339-48. PubMed ID: 9486769
    [Abstract] [Full Text] [Related]

  • 13. Activation of metabotropic glutamate receptors increases neuropeptide Y expression in the rat hippocampus. Immunohistochemical studies.
    Smiałowska M, Bajkowska M.
    Pol J Pharmacol; 1997 Feb 01; 49(5):357-62. PubMed ID: 9566036
    [Abstract] [Full Text] [Related]

  • 14. Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus.
    Pałucha A, Brański P, Tokarski K, Bijak M, Pilc A.
    Pol J Pharmacol; 1997 Feb 01; 49(6):495-7. PubMed ID: 9566055
    [Abstract] [Full Text] [Related]

  • 15. Immunocytochemical and pharmacological characterization of metabotropic glutamate receptors of the vestibular end organs in the frog.
    Andrianov GN, Puyal J, Raymond J, Ventéo S, Demêmes D, Ryzhova IV.
    Hear Res; 2005 Jun 01; 204(1-2):200-9. PubMed ID: 15925205
    [Abstract] [Full Text] [Related]

  • 16. Involvement of hippocampal metabotropic glutamate receptors in radial maze performance.
    Hayashi K, Yoshihara T, Ichitani Y.
    Neuroreport; 2007 May 07; 18(7):719-23. PubMed ID: 17426606
    [Abstract] [Full Text] [Related]

  • 17. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioral and Fos immunohistochemical study.
    Kaatz KW, Albin RL.
    Neuroscience; 1995 May 07; 66(1):55-65. PubMed ID: 7637875
    [Abstract] [Full Text] [Related]

  • 18. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.
    Fedosiewicz-Wasiluk M, Hoły ZZ, Wiśniewska RJ, Wiśniewski K.
    Amino Acids; 2005 Feb 07; 28(1):111-7. PubMed ID: 15700110
    [Abstract] [Full Text] [Related]

  • 19. Metabotropic glutamate receptor agonist (1S,3R-ACPD) increased frontal cortex dopamine release in aged but not in young rats.
    Pintor A, Tiburzi F, Pezzola A, Volpe MT.
    Eur J Pharmacol; 1998 Oct 23; 359(2-3):139-42. PubMed ID: 9832384
    [Abstract] [Full Text] [Related]

  • 20. Phospholipase C-independent group I metabotropic glutamate receptor-mediated inward current in mouse purkinje cells.
    Hirono M, Konishi S, Yoshioka T.
    Biochem Biophys Res Commun; 1998 Oct 29; 251(3):753-8. PubMed ID: 9790982
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.